Cardinal Health, Inc. (NYSE:CAH) Shares Bought by Vestor Capital LLC

Vestor Capital LLC lifted its position in shares of Cardinal Health, Inc. (NYSE:CAH - Free Report) by 197.0% in the third quarter, according to its most recent 13F filing with the SEC. The firm owned 158,508 shares of the company's stock after purchasing an additional 105,131 shares during the quarter. Cardinal Health comprises approximately 1.4% of Vestor Capital LLC's holdings, making the stock its 18th largest holding. Vestor Capital LLC owned approximately 0.07% of Cardinal Health worth $17,518,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors also recently modified their holdings of the stock. Paragon Capital Management Inc. lifted its position in Cardinal Health by 0.7% in the 2nd quarter. Paragon Capital Management Inc. now owns 14,758 shares of the company's stock valued at $1,451,000 after purchasing an additional 99 shares during the last quarter. Midland Wealth Advisors LLC boosted its position in Cardinal Health by 4.2% during the 2nd quarter. Midland Wealth Advisors LLC now owns 2,488 shares of the company's stock worth $245,000 after acquiring an additional 100 shares during the period. Aptus Capital Advisors LLC grew its holdings in shares of Cardinal Health by 5.1% during the 2nd quarter. Aptus Capital Advisors LLC now owns 2,071 shares of the company's stock valued at $204,000 after acquiring an additional 100 shares in the last quarter. Oregon Public Employees Retirement Fund raised its position in Cardinal Health by 0.5% during the second quarter. Oregon Public Employees Retirement Fund now owns 20,891 shares of the company's stock valued at $2,054,000 after acquiring an additional 100 shares in the last quarter. Finally, Blair William & Co. IL boosted its stake in shares of Cardinal Health by 0.9% during the 2nd quarter. Blair William & Co. IL now owns 11,442 shares of the company's stock worth $1,125,000 after acquiring an additional 103 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company's stock.

Cardinal Health Stock Performance

Shares of NYSE CAH traded down $4.23 during mid-day trading on Monday, hitting $111.90. 4,392,607 shares of the stock traded hands, compared to its average volume of 2,084,298. Cardinal Health, Inc. has a 52 week low of $93.17 and a 52 week high of $119.13. The company has a market cap of $27.08 billion, a price-to-earnings ratio of 21.77, a PEG ratio of 1.49 and a beta of 0.60. The stock has a fifty day moving average price of $111.75 and a 200-day moving average price of $104.15.

Cardinal Health (NYSE:CAH - Get Free Report) last posted its quarterly earnings results on Friday, November 1st. The company reported $1.88 EPS for the quarter, beating analysts' consensus estimates of $1.64 by $0.24. The business had revenue of $52.28 billion for the quarter, compared to analysts' expectations of $50.90 billion. Cardinal Health had a negative return on equity of 54.85% and a net margin of 0.37%. The business's quarterly revenue was down 4.3% on a year-over-year basis. During the same period last year, the firm earned $1.73 earnings per share. As a group, sell-side analysts predict that Cardinal Health, Inc. will post 7.61 EPS for the current fiscal year.

Cardinal Health Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, October 15th. Investors of record on Tuesday, October 1st were given a dividend of $0.506 per share. The ex-dividend date of this dividend was Tuesday, October 1st. This is an increase from Cardinal Health's previous quarterly dividend of $0.51. This represents a $2.02 dividend on an annualized basis and a yield of 1.81%. Cardinal Health's payout ratio is currently 39.30%.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on CAH shares. Deutsche Bank Aktiengesellschaft lifted their price objective on Cardinal Health from $119.00 to $124.00 and gave the stock a "hold" rating in a report on Monday. JPMorgan Chase & Co. upped their target price on shares of Cardinal Health from $111.00 to $123.00 and gave the company a "neutral" rating in a research report on Wednesday, August 21st. UBS Group boosted their price objective on shares of Cardinal Health from $134.00 to $139.00 and gave the company a "buy" rating in a report on Monday. Robert W. Baird increased their target price on Cardinal Health from $130.00 to $137.00 and gave the stock an "outperform" rating in a research note on Thursday, August 15th. Finally, Evercore ISI increased their price objective on Cardinal Health from $105.00 to $115.00 and gave the stock an "in-line" rating in a report on Thursday, August 15th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and eight have assigned a buy rating to the stock. According to data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and an average target price of $123.00.

Insider Buying and Selling

In other news, insider Jessica L. Mayer sold 16,573 shares of the company's stock in a transaction that occurred on Wednesday, August 21st. The stock was sold at an average price of $109.39, for a total value of $1,812,920.47. Following the completion of the sale, the insider now directly owns 75,971 shares in the company, valued at $8,310,467.69. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. In other news, insider Jessica L. Mayer sold 16,573 shares of the firm's stock in a transaction that occurred on Wednesday, August 21st. The shares were sold at an average price of $109.39, for a total value of $1,812,920.47. Following the completion of the transaction, the insider now owns 75,971 shares of the company's stock, valued at approximately $8,310,467.69. This trade represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Jessica L. Mayer sold 17,896 shares of Cardinal Health stock in a transaction that occurred on Thursday, August 15th. The stock was sold at an average price of $106.48, for a total transaction of $1,905,566.08. Following the completion of the transaction, the insider now owns 94,529 shares of the company's stock, valued at $10,065,447.92. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold a total of 113,963 shares of company stock valued at $12,379,980 over the last ninety days. Company insiders own 0.09% of the company's stock.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.